More about

Heart Failure

News
April 25, 2022
1 min read
Save

SODIUM-HF

SODIUM-HF

Long-term effects of sodium restriction on clinical outcomes in patients with HF.

News
April 24, 2022
2 min read
Save

‘Hear Your Heart’ initiative aims to address HF disparities for Black, Latina women

‘Hear Your Heart’ initiative aims to address HF disparities for Black, Latina women

A new health initiative will provide tailored resources for women with HF, particularly Black and Latina women, as part of an effort to reduce race and sex disparities in treatment and outcomes, according to an industry press release.

News
April 22, 2022
3 min watch
Save

VIDEO: NKF chief medical officer reviews late-breaking trials

VIDEO: NKF chief medical officer reviews late-breaking trials

BOSTON — In this video from the National Kidney Foundation Spring Clinical Meetings, Joseph A. Vassalotti, MD, reviews results from late-breaking clinical trials.

News
April 21, 2022
2 min read
Save

Increased mortality risk for men with type 1 diabetes, regardless of cognitive ability

Increased mortality risk for men with type 1 diabetes, regardless of cognitive ability

Swedish men diagnosed with type 1 diabetes in youth had higher all-cause and cardiovascular mortality risks compared with those without diabetes, and cognitive ability did not influence the associations, according to study data.

News
April 20, 2022
1 min read
Save

SEISMiC topline results: Istaroxime improves systolic BP profile in cardiogenic shock

SEISMiC topline results: Istaroxime improves systolic BP profile in cardiogenic shock

In the phase 2 SEISMiC trial, istaroxime met its primary endpoint of improving systolic BP profile at 6 hours in patients with cardiogenic shock, according to the topline results announced by Windtree Therapeutics.

News
April 20, 2022
1 min read
Save

Fenofibrate may lower heart failure hospitalization, CV mortality in type 2 diabetes

Fenofibrate may lower heart failure hospitalization, CV mortality in type 2 diabetes

In a cohort of patients with type 2 diabetes treated with simvastatin, fenofibrate decreased the composite of heart failure hospitalizations or cardiovascular mortality, according to an analysis of the ACCORD Lipid trial.

News
April 19, 2022
1 min watch
Save

Video: New guidelines help relabel heart failure

Video: New guidelines help relabel heart failure

In this video, David E. Lanfear, MD, MS, FHFSA, advanced HF specialist and program director of the Advanced Heart Failure Fellowship at the Henry Ford Health System in Detroit, discusses the new HF guidelines presented at the American College of Cardiology Scientific Session.

News
April 18, 2022
2 min read
Save

Infertility may predict HF risk in women

Infertility may predict HF risk in women

Women reporting a history of infertility had an almost 20% increased risk for developing HF during 15 years of follow-up, particularly HF with preserved ejection fraction, according to an analysis of Women’s Health Initiative data.

News
April 18, 2022
3 min read
Save

Combination SGLT2, GLP-1 therapy lowers risk for adverse CV outcomes in type 2 diabetes

Combination SGLT2, GLP-1 therapy lowers risk for adverse CV outcomes in type 2 diabetes

Combined use of an SGLT2 inhibitor and GLP-1 receptor agonist is associated with reduced odds for major adverse cardiac and cerebrovascular events and heart failure in adults with type 2 diabetes, according to study findings.

News
April 16, 2022
2 min read
Save

Editors of HF journal question use of the word ‘candidate’

Editors of HF journal question use of the word ‘candidate’

The word “candidate” is often used when determining whether a patient with HF will benefit from a particular therapy, but an editorial in the Journal of Cardiac Failure states the term may be too judgmental.

View more